Industry News
HPV-positive SCCOP patients' recurrence differs from HPV-negative patients
Feb 24, 2014
Patients with HPV-positive squamous cell carcinoma of the oropharynx (SCCOP) had a longer time to development of distant metastasis (DM) after initial treatment, and had more metastatic sites in more atypical locations compared to HPV-negative patients, according to research presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium. Read More
Identifying men with advanced prostate cancer through genetic screening
Feb 24, 2014
Screening men with a family history of prostate cancer for a range of gene mutations can identify those who are at high risk of aggressive forms of the disease and in need of lifelong monitoring, a new study has shown. Read More
Double the survival rate for HPV-positive OPSCC patients compared to HPV-negative patients
Feb 24, 2014
A retrospective analysis of oropharyngeal patients with recurrence of disease after primary therapy in the Radiation Therapy Oncology Group (RTOG) studies 0129 or 0522 found that HPV-positive patients had a higher overall survival (OS) rate than HPV-negative patients (at two years post-treatment, 54.6 percent vs. 27. Read More
Promising skin tumor vaccine offers hope for transplant patients
Feb 24, 2014
Papillomaviruses (linked to cervical cancer when they infect the mucosal tissue in the female reproductive tract) can also infect normal skin, where they cause warts and possibly non-melanoma skin cancer, mostly in immune-suppressed organ transplant patients. An article published in PLOS Pathogens suggests that vaccination might prevent virus-associated benign and malignant skin tumors. Read More
Selenium and vitamin E supplements 'increase prostate cancer risk'
Feb 24, 2014
A new study recently published in the Journal of the National Cancer Institute suggests that taking high doses of selenium and vitamin E supplements may increase the risk of prostate cancer, depending on a man's selenium levels prior to taking the supplements.The research team, including first author Dr. Read More
Quality of voice and speech affected post-treatment in patients with oropharyngeal cancer
Feb 24, 2014
Oropharyngeal cancer patients treated with combined chemotherapy and radiation therapy reported a decrease in their voice and speech quality (VSQ) for up to one year after the completion of treatment, according to research presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium. Read More
Improved patient-reported salivary function following reduced RT dose to bilateral IB lymph nodes
Feb 24, 2014
For head and neck cancer patients undergoing radiation therapy, a reduction in the amount of radiation treatment volume to the submandibular (level IB) lymph nodes resulted in better patient-reported salivary function, according to research presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium. Read More
Favorable outcomes reported in unilateral radiation therapy for advanced stage tonsil cancer
Feb 24, 2014
Limiting radiation therapy to lymph nodes on one side of the neck for advanced tonsil cancer resulted in good local regional control and no cancer recurrence on the untreated side, according to research presented at the 2014 Multidisciplinary Head and Neck Cancer Symposium. Read More
Secondary thyroid cancer more deadly than primary malignancy in young individuals
Feb 24, 2014
A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer. Read More
Cognitive behavioral therapy plus hypnosis reduces fatigue in radiotherapy breast cancer patients
Feb 24, 2014
Breast cancer patients receiving radiotherapy showed decreased fatigue as a result of cognitive behavioral therapy plus hypnosis (CBTH), according to a study recently published in the Journal of Clinical Oncology. Read More
Previous Page Next Page